Interleukin 6 receptor inhibition in primary Sjögren syndrome: a multicentre double-blind randomised placebo-controlled trial.

Felten R, Devauchelle-Pensec V, Seror R, Duffau P, Saadoun D, Hachulla E, Pierre Yves H, Salliot C, Perdriger A, Morel J, Mékinian A, Vittecoq O, Berthelot JM, Dernis E, Le Guern V, Dieudé P, Larroche C, Richez C, Martin T, Zarnitsky C, Blaison G, Kieffer P, Maurier F, Dellal A, Rist S, Andres E, Contis A, Chatelus E, Sordet C, Sibilia J, Arnold C, Tawk MY, Aberkane O, Holterbach L, Cacoub P, Saraux A, Mariette X, Meyer N, Gottenberg JE

Open source

DOI: 10.1136/annrheumdis-2020-218467
Published: 2021 Mar
Container: Annals of the rheumatic diseases
Publisher: Not recorded
Open access: unknown

Credibility signals

limited evidence Score 43/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

cautionDOI registered: No matching Crossref record was present in this response. Source: Crossref; license: CC0 metadata
cautionDOI resolves: No matching Crossref record was present in this response. Source: Crossref; license: CC0 metadata
not scoredDirectory of Open Access Journals: No matching DOAJ record was present in this response. No allow-list match; this is not evidence of low credibility. Source: DOAJ; license: CC0
not scoredMEDLINE indexed: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredOpenAlex core source: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredKnown publisher allow-list: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredROR affiliation: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredRetraction Watch retraction: No retraction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch expression of concern: No expression of concern notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch correction: No correction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch reinstatement: No reinstatement notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredOpen access status: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredPublication license: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredPublication version: A publication version was supplied but is not scored. Source: Normalized work metadata; license: Caller-provided; provenance license not supplied to scorer
cautionMetadata completeness: 5 of 6 scored descriptive metadata groups are present; missing fields increase uncertainty. Source: Normalized work metadata; license: Caller-provided; provenance license not supplied to scorer

Cite this work

BibTeX

@article{allodium:10.1136/annrheumdis-2020-218467,
  title = {Interleukin 6 receptor inhibition in primary Sjögren syndrome: a multicentre double-blind randomised placebo-controlled trial.},
  author = {Felten R and Devauchelle-Pensec V and Seror R and Duffau P and Saadoun D and Hachulla E and Pierre Yves H and Salliot C and Perdriger A and Morel J and Mékinian A and Vittecoq O and Berthelot JM and Dernis E and Le Guern V and Dieudé P and Larroche C and Richez C and Martin T and Zarnitsky C and Blaison G and Kieffer P and Maurier F and Dellal A and Rist S and Andres E and Contis A and Chatelus E and Sordet C and Sibilia J and Arnold C and Tawk MY and Aberkane O and Holterbach L and Cacoub P and Saraux A and Mariette X and Meyer N and Gottenberg JE},
  year = {2021},
  journal = {Annals of the rheumatic diseases},
  doi = {10.1136/annrheumdis-2020-218467},
  url = {https://doi.org/10.1136/annrheumdis-2020-218467}
}

RIS

TY  - JOUR
TI  - Interleukin 6 receptor inhibition in primary Sjögren syndrome: a multicentre double-blind randomised placebo-controlled trial.
AU  - Felten R
AU  - Devauchelle-Pensec V
AU  - Seror R
AU  - Duffau P
AU  - Saadoun D
AU  - Hachulla E
AU  - Pierre Yves H
AU  - Salliot C
AU  - Perdriger A
AU  - Morel J
AU  - Mékinian A
AU  - Vittecoq O
AU  - Berthelot JM
AU  - Dernis E
AU  - Le Guern V
AU  - Dieudé P
AU  - Larroche C
AU  - Richez C
AU  - Martin T
AU  - Zarnitsky C
AU  - Blaison G
AU  - Kieffer P
AU  - Maurier F
AU  - Dellal A
AU  - Rist S
AU  - Andres E
AU  - Contis A
AU  - Chatelus E
AU  - Sordet C
AU  - Sibilia J
AU  - Arnold C
AU  - Tawk MY
AU  - Aberkane O
AU  - Holterbach L
AU  - Cacoub P
AU  - Saraux A
AU  - Mariette X
AU  - Meyer N
AU  - Gottenberg JE
PY  - 2021
JO  - Annals of the rheumatic diseases
DO  - 10.1136/annrheumdis-2020-218467
UR  - https://doi.org/10.1136/annrheumdis-2020-218467
ER  -

APA

R, F., V, D., R, S., P, D., D, S., E, H., H, P. Y., C, S., A, P., J, M., A, M., O, V., JM, B., E, D., V, L. G., P, D., C, L., C, R., T, M., C, Z., G, B., P, K., F, M., A, D., S, R., E, A., A, C., E, C., C, S., J, S., C, A., MY, T., O, A., L, H., P, C., A, S., X, M., N, M., & JE, G. (2021). Interleukin 6 receptor inhibition in primary Sjögren syndrome: a multicentre double-blind randomised placebo-controlled trial.. Annals of the rheumatic diseases. https://doi.org/10.1136/annrheumdis-2020-218467

Source records

pubmed · retrieved 2026-09-26T13:22:38.238Z